Revolutionizing Tissue Therapeutics w/ Dimension Bio CEO Caralynn Nowinski Collens, M.D.

Dimension Bio CEO Caralynn Nowinski Collens, M.D., discusses the company's mission to create life-saving regenerative therapies, particularly for liver disease. She shares her journey in the startup world, the increasing demand for liver treatments, and the innovative approaches Dimension Bio is taking with cell-based therapies. The conversation also touches on recent advancements, regulatory challenges, and future predictions for the field of regenerative medicine.Chapters00:00 Introduction to Dimension Bio and Its Mission02:39 Caralynn's Journey and Leadership in Startups05:13 The Growing Need for Liver Disease Treatments08:23 Understanding Cell-Based Therapies11:15 Recent Milestones and Innovations in Therapy14:03 The Mechanism of Action and Placement of Therapies16:59 Regulatory Landscape and Future Predictions19:40 Final Thoughts and Future Aspirations